NDRG2 Expression Decreases Tumor-Induced Osteoclast Differentiation by Down-regulating ICAM1 in Breast Cancer Cells.
10.4062/biomolther.2015.105
- Author:
Bomi KIM
1
;
Sorim NAM
;
Ji Hyun LIM
;
Jong Seok LIM
Author Information
1. Department of Biological Science and the Research Center for Women's Disease, Sookmyung Women's University, Seoul 04310, Republic of Korea. jslim@sookmyung.ac.kr
- Publication Type:Original Article
- Keywords:
NDRG2;
ICAM1;
Osteoclast;
Osteolytic metastasis;
Tumor environment
- MeSH:
Bone Matrix;
Bone Resorption;
Breast Neoplasms*;
Breast*;
Culture Media, Conditioned;
Cytokines;
Down-Regulation;
Intercellular Adhesion Molecule-1;
Ligands;
Neoplasm Metastasis;
Osteoblasts;
Osteoclasts*;
RNA, Messenger;
Tumor Microenvironment
- From:Biomolecules & Therapeutics
2016;24(1):9-18
- CountryRepublic of Korea
- Language:English
-
Abstract:
Bone matrix is properly maintained by osteoclasts and osteoblasts. In the tumor microenvironment, osteoclasts are increasingly differentiated by the various ligands and cytokines secreted from the metastasized cancer cells at the bone metastasis niche. The activated osteoclasts generate osteolytic lesions. For this reason, studies focusing on the differentiation of osteoclasts are important to reduce bone destruction by tumor metastasis. The N-myc downstream-regulated gene 2 (NDRG2) has been known to contribute to the suppression of tumor growth and metastasis, but the precise role of NDRG2 in osteoclast differentiation induced by cancer cells has not been elucidated. In this study, we demonstrate that NDRG2 expression in breast cancer cells has an inhibitory effect on osteoclast differentiation. RAW 264.7 cells, which are monocytic preosteoclast cells, treated with the conditioned media (CM) of murine breast cancer cells (4T1) expressing NDRG2 are less differentiated into the multinucleated osteoclast-like cells than those treated with the CM of 4T1-WT or 4T1-mock cells. Interestingly, 4T1 cells stably expressing NDRG2 showed a decreased mRNA and protein level of intercellular adhesion molecule 1 (ICAM1), which is known to enhance osteoclast maturation. Osteoclast differentiation was also reduced by ICAM1 knockdown in 4T1 cells. In addition, blocking the interaction between soluble ICAM1 and ICAM1 receptors significantly decreased osteoclastogenesis of RAW 264.7 cells in the tumor environment. Collectively, these results suggest that the reduction of ICAM1 expression by NDRG2 in breast cancer cells decreases osteoclast differentiation, and demonstrate that excessive bone resorption could be inhibited via ICAM1 down-regulation by NDRG2 expression.
